31 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
	58	Non-glycosidic/non-aminoalkyl-substituted indolocarbazoles as inhibitors of protein kinase C	TBA
11451670	11	Hexosaminidase inhibitors as new drug candidates for the therapy of osteoarthritis.	The Scripps Research Institute
10322126	60	Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase.	Northwestern University
16789731	3	Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.	University of Michigan
16759082	9	Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction.	University of Michigan
19072652	64	Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.	Medical University of South Carolina
17614275	16	Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.	Eli Lilly
11567092	4	Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors.	Gsk
17049867	5	Synthesis of beta-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases.	Crefsip
17444623	29	Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.	Schering-Plough Research Institute
17120228	14	Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.	The Procter & Gamble Pharmaceuticals
17696512	50	Design and Synthesis of HIV-1 Protease Inhibitors Incorporating Oxazolidinones as P2/P2' Ligands in Pseudosymmetric Dipeptide Isosteres.	University of Massachusetts Medical School
16495061	8	Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agent.	Johnson & Johnson Pharmaceutical
16982192	8	Arylsulfonamides: a study of the relationship between activity and conformational preferences for a series of factor Xa inhibitors.	Glaxosmithkline
16279769	28	Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.	Sapienza University of Rome
15689148	19	Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors.	Shanghai Institute of Materia Medica
15985434	18	Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives.	Chinese Academy of Sciences
15664516	21	Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases.	University of Dundee
16023344	120	Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.	Merck Frosst Canada
12852749	11	First dual aromatase-steroid sulfatase inhibitors.	University of Bath
8667367	28	Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.	Tohoku College of Pharmacy
15911319	10	Synthesis and characterization of azole isoflavone inhibitors of aromatase.	Ohio State University